PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 5, 2026Cancer Research0 citations

Abstract 4770: Molecular features of patient-derived triple-negative breast cancer models based on super-enhancer-associated transcriptional regulators and biomarkers

View Full Paper
KHKuniko HorieKIKazuo IkedaSISatoshi Inoue

Key Points

  • The aim is to analyze super-enhancer-associated gene profiles in patient-derived TNBC models to understand their molecular features.
  • Integrated RNA-sequencing and chromatin immunoprecipitation for H3K27ac binding
  • Identification of SE-associated genes using patient-derived models
  • Spheroid culture technique for model generation
  • Silencing MYBL1 in TNBC models to assess its role in proliferation
  • Identification of predominant SE-associated genes like CD44 and MYC
  • MYBL1 found as a critical transcription factor for basal-like TNBC
  • Silencing MYBL1 reduced cell proliferation and affected mitosis-associated gene expression
  • MYBL1 immunoreactivity correlated with poor prognosis in TNBC patients

Abstract

Abstract Super-enhancers (SEs) have been defined as particular genomic regions with clusters of consecutive enhancers, which provide cell- or stage-specific context. SEs are often determined by high-level enrichment for genomic binding of transcriptional coactivators and active chromatin marks such as histone H3 with acetylated K27. In this study, we aim to characterize similarity and specificity of SE-associated gene profiles of patient-derived models of triple-negative breast cancer (TNBC) obtained from distinct advanced cases. We identified SE-associated genes for these models based on the integrated study of RNA-sequencing and chromatin immunoprecipitation (ChIP) sequencing for H3K27ac binding. Since these patient-derived cancer models were generated through a spheroid culture technique, stemness markers such as CD44 and MYC were identified as predominant SE-associated genes in the majority of cases. We further identified MYBL1 as a critical SE-associated transcription factor among basal-like cancer cases. Silencing of MYBL1 in TNBC patient-derived and cell line models showed that this transcription factor contributes to cell proliferation and the regulation of mitosis-associated gene expression. Immunohistochemical study for MYBL1 in our TNBC cohort showed that MYBL1 immunoreactivity is a potential poor prognostic factor for TNBC patients. The present findings suggest that the characterization of SE-associated transcriptional regulators and biomarkers will facilitate the understanding of molecular features of TNBC subtypes and the development of alternative potential therapeutic targets for the advanced disease. Citation Format: Kuniko Horie, Kazuhiro Ikeda, Satoshi Inoue. Molecular features of patient-derived triple-negative breast cancer models based on super-enhancer-associated transcriptional regulators and biomarkers abstract. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 4770.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Horie et al. (2026) studied this question.

synapsesocial.com/papers/69d1fd13a79560c99a0a2d90https://doi.org/10.1158/1538-7445.am2026-4770
Ask AI
Helpful
Bookmark
Share
View Full Paper